| Literature DB >> 16039954 |
Chikako Fukukawa1, Nobuhiro Tanuma, Tadashi Okada, Kunimi Kikuchi, Hiroshi Shima.
Abstract
In this study, we focus on the potential interaction of pp32/I-1(PP2A) (pp32) with the Raf-MEK-ERK signaling pathway. We show that overexpressed pp32 suppresses Raf-1 activation, thereby downregulating the level of ERK activation. This suppression of Raf-1 requires the C-terminal half of pp32. Conversely, knock-down of PP32 by siRNA enhances ERK and MEK activations. Taken together, we propose that tumor-suppression by pp32 is, at least in part, mediated by downregulation of the Raf-MEK-ERK signaling pathway.Entities:
Mesh:
Substances:
Year: 2004 PMID: 16039954 DOI: 10.1016/j.canlet.2004.11.026
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679